×

Lightning Round OT: RIMM, Genentech and More

Research In Motion : The stock’s up a quick 15 points, so Cramer recommended investors schnitzel a little and then sell the rest after the April 2 earnings report.

Dolby : The home theater business inevitably will suffer with housing overall, so Dolby’s a sell.

Genentech : “I see Avastin sales ramping,” Cramer said, so DNA’s a buy.




Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com